Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,490.00
-30.00 (-0.54%)
At close: Sep 15, 2025
Wonbiogen Revenue
Wonbiogen had revenue of 8.40B KRW in the quarter ending June 30, 2025, with 5.02% growth. This brings the company's revenue in the last twelve months to 32.02B, up 8.96% year-over-year. In the year 2024, Wonbiogen had annual revenue of 30.44B with 2.79% growth.
Revenue (ttm)
32.02B
Revenue Growth
+8.96%
P/S Ratio
1.21
Revenue / Employee
421.38M
Employees
n/a
Market Cap
38.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.44B | 824.93M | 2.79% |
| Dec 31, 2023 | 29.61B | 2.87B | 10.72% |
| Dec 31, 2022 | 26.75B | 9.03B | 50.94% |
| Dec 31, 2021 | 17.72B | 5.70B | 47.46% |
| Dec 31, 2020 | 12.02B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |